Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-006314
Filing Date
2025-01-27
Accepted
2025-01-27 16:00:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10644
2 EXHIBIT I tm254541d1_ex-1.htm EX-99.1 5616
  Complete submission text file 0001104659-25-006314.txt   18142
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022
Business Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

EIN.: 980330397 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91363 | Film No.: 25558793
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)